PRTC PureTech Health

resTORbio Files Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

resTORbio, Inc. today announced that it has previously confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to commence after the SEC completes its review process, subject to market and other conditions.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (“Securities Act”). This announcement is being issued in accordance with Rule 135 under the Securities Act.

EN
05/12/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PureTech Health

Puretech Health: 4 directors

Four Directors at Puretech Health bought 234,640 shares at between 123p and 125p. The significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: PureTech Health plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: PureTech Health plc 08-Apr-2025 / 14:46 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(...

Liberum Research Team
  • Liberum Research Team

LIBERUM: Morning Comment

SAS Sentiment and Screens, Commodity snapSHOT, IAG, Endeavour Mining, Hargreaves Lansdown, Trainline, SIG, Cake Box, Aptamer, Market Highlights

Liberum Research Team
  • Liberum Research Team

LIBERUM: UK Small & Mid Cap Dispatches

SAS Sentiment and Screens, Commodity snapSHOT, Trainline, SIG, Cake Box, Aptamer, SMID Market Highlights

Liberum Research Team
  • Liberum Research Team

UK Small & Mid Cap Dispatches: Strategy - Equity market horse race, Al...

Strategy - Equity market horse race, Alts M&A up significantly in April, PureTech Health, Ferro-Alloy Resources, SMID Market Highlights

ResearchPool Subscriptions

Get the most out of your insights

Get in touch